Clinical Trials > SAVER  

  • Information
  • Sites - Interested
SAVER   

Title

Sodium Valproate for Epigenetic Re-programming in Management of High Risk Oral Epithelial Dysplasia: a randomised, double blind, placebo controlled clinical trial with embedded mechanistic and feasibility studies.


Basic Trial Information

Phase Type Status Age Sponsor Protocol IDs Recruitment
II Open The University of Liverpool 0

Trial Start Date

24/09/2019


Trial Coordinator

Binyam Tesfaye


Trial Coordinator Email Address

btesfaye@liverpool.ac.uk


Trial Coordinator Contact No

0151 795 7328



UK: SCOTLAND

  • Glasgow, Queen Elizabeth University Hospital (James McCaul)

Login

Username:
Password:

Lost Username / Password?